高血压药物市场，[通过高血压型（原发性高血压，继发性高血压），通过治疗型（β受体阻滞剂血管扩张剂，钙通道阻断剂，血管紧张素转换酶，利尿剂，血管紧张素受体阻滞剂，肾素抑制剂）];和地理 - 趋势，分析和预测直到2025年

发布日期：2018年7月
页数：0
格式：PDF.
Report ID: PM1331
基准年：
历史数据：

报告摘要

由于各种因素，观察到全球高血压药物市场规模以增加，包括患有高血压的人口计数增加。

Hypertension is defined as a condition where arteries in the heart has continuously elevated pressure. It is also referred to as high blood pressure (HBP). According to American Heart Association 2017, hypertension is defined as a condition of blood pressure higher than 130 and 80 millimetres of mercury (mmHg). The measurement of blood pressure is expressed in terms namely; systolic pressure and diastolic pressure. An individual suffering from hypertension for long time has major risk of heart stroke, heart failure, atrial fibrillation, dementia, and vision loss.

血压进一步分为初级高血压和次要高血压。由于改变生活方式和各种遗传因素，初级高血压占其越来越多的市场份额。原发性高血压主要受到因素的影响;饮食中多余的盐，体重过多，摄入过量的酒精，活跃或被动吸烟。然而，次要高血压占市场份额较小。次要高血压易于识别出包括慢性肾病，内分泌疾病，过度使用的避孕药。

According to Centres for Disease Control and Prevention (CDC), high blood pressure or hypertension is the major cause of heart disease, and heart stroke in the U.S. Moreover, approximately 32% of adults have high blood pressure in the U.S. which accounts for the ratio of 1 in every 3 adults. Additionally, high blood pressure is becoming one of the leading causes of death in North America during recent past.

Rising demand for effective treatment of high blood pressure and high number of drug patent expiration will support the growth of global market.

The global market is primarily driven by the factors such as growing number of patients suffering from high blood pressures globally. Hypertension majorly causes cardiovascular diseases like heart stroke, and heart failure which cause higher number of deaths. As per 2013 WHO reports, approximately 45% of heart related deaths were due to hypertension. Moreover, the rising preference for the sedentary lifestyle in the developing countries is another factor contributing to the growth of hypertension cases.

增加专利药物到期的到期都在现有市场创造了利润丰厚的机会。此外，越来越多的普通药物的数量和可用性也应提高该市场的增长。此外，地方政府的利益上升及其对推动全球市场的耐心援助的焦点。

然而，通过使用高血压药物的相对副作用和发展中国家的替代疗法的可用性可以在不久的将来妨碍高血压药物市场的生长。

全球高血压药物市场分类

全球高血压药物市场在高血压型，治疗型和地理的基础上进行分段。

On the basis of hypertension type, global hypertension drug market is segmented into:

初级高血压
二次高血压

在治疗类型的基础上，全球高血压药物市场被分段为：

Beta阻止血管扩张器
钙通道阻滞剂
Angiotensin Converting Enzyme
Diuretics
Angiotensin Receptor Blockers
肾素抑制剂。

Geographically, the global hypertension drug market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

增加高血压的患病率，有效地发展导致全球北美的高血压药物。

地理位置,市场被分割为North America, Europe, Asia Pacific, Latin America & Middle East and Africa. Among the region, North America is expected to dominate this market during the forecast period. The North American region holds major share of this market owing to rising number of patients suffering from hypertension, and is one of the leading cause of death in this region. Also, increasing awareness for the use of alternative drugs, and increasing geriatric population in North America are factors enhancing the hypertension drug market in the near future.

但是，亚太地区预计将在预测期间见证市场快速增长。越来越多的高血压患者以及对使用各种药物和疗法的升高意识是预计在即将到来的几年期间管理全球市场的主要因素。